Who owns KIORA PHARMACEUTICALS INC?
- Ticker: KPRX
- CUSIP Number: 49721t507
Tip: Access positions for across all investors
Analyze quarterly positions in Kiora Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kiora Pharmaceuticals stock
Who bought or sold KIORA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| ADAR1 Capital Management | 168k | $324k | 0% | Mar 2026 |
|
| Citadel Advisors | 50k | $96k | 121% | Mar 2026 |
|
| Geode Capital Management | 48k | $92k | 117% | Mar 2026 |
|
| Vanguard Capital Management | 20k | $38k | 100% | Mar 2026 |
|
| XTX Topco | 15k | $28k | 23% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 13k | $25k | 100% | Mar 2026 |
|
| Two Sigma Securities | 12k | $23k | 100% | Mar 2026 |
|
| Rangeley Capital | 10k | $19k | 100% | Mar 2026 |
|
| Morgan Stanley | 1.4k | $2.7k | 100% | Mar 2026 |
|
| UBS Group | 1.3k | $2.5k | 43% | Mar 2026 |
|
| Tower Research Capital | 995.00 | $1.9k | -37% | Mar 2026 |
|
| SBI Securities | 256.00 | $494.003200 | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 200.00 | $386.000000 | 100% | Mar 2026 |
|
| BlackRock | 58.00 | $111.998000 | 0% | Mar 2026 |
|
| Goss Wealth Management | 22.00 | $42.000200 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 6.00 | $12.000000 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 2.00 | $3.000000 | 0% | Mar 2026 |
|
| Activest Wealth Management | 2.00 | $4.000000 | 0% | Mar 2026 |
|
Who sold out of Kiora Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Stonepine Capital Management | Dec 2025 | 131k | $258k |
| DRW Holdings | Dec 2025 | 110k | $217k |
| Nantahala Capital Management | Dec 2025 | 106k | $209k |
| Alyeska Investment Group | Dec 2025 | 77k | $152k |
| Renaissance Technologies | Dec 2025 | 21k | $42k |
| Miller Wealth Advisors | Dec 2025 | 1.0k | $2.0k |